<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet><Article><Journal><PublisherName>Avicenna Organ Transplant Institute</PublisherName><JournalTitle>International Journal of Organ Transplantation Medicine</JournalTitle><Issn>2000-6490</Issn><Volume>1</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2010</Year><Month>01</Month><Day>22</Day></PubDate></Journal><ArticleTitle>Liver Transplantation in the Presence of Old Portal Vein Thrombosis</ArticleTitle><FirstPage>9</FirstPage><LastPage>9</LastPage><Language>EN</Language><AuthorList><Author><FirstName>F</FirstName><LastName>Kakaei</LastName><Affiliation>Organ Transplant Research Center, Nemazi Hospital, Shiraz University of Medical Science, Shiraz. fkakaei@yahoo.com</Affiliation></Author><Author><FirstName>S</FirstName><LastName>Nikeghbalian</LastName></Author><Author><FirstName>H</FirstName><LastName>Salahi</LastName></Author><Author><FirstName>A</FirstName><LastName>Bahador</LastName></Author><Author><FirstName>K</FirstName><LastName>Kazemi</LastName></Author><Author><FirstName>M</FirstName><LastName>Dehghani</LastName></Author><Author><FirstName>A</FirstName><LastName>Shamsaeefar</LastName></Author><Author><FirstName>B</FirstName><LastName>Sanei</LastName></Author><Author><FirstName>S</FirstName><LastName>Ghaffaripour</LastName></Author><Author><FirstName>E</FirstName><LastName>Rajaei</LastName></Author><Author><FirstName>S</FirstName><LastName>Gholami</LastName></Author><Author><FirstName>S A</FirstName><LastName>Malek-Hosseini</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2010</Year><Month>01</Month><Day>22</Day></PubDate></History><Abstract>Background: Portal vein thrombosis (PVT) has been mentioned as a potential obstacle to liver transplantation (LTx).Objective: To review the impact of PVT on orthotopic liver transplant (OLT) outcome.Method: Between January 2006 and April 2009, 440 OLT were performed in Shiraz Transplant Unit of whom, 35 (7.9%) cases had old PVT with recanalization. Data were retrospectively collected regarding the demographics,indication for OLT, Child-Turgot-Pugh classification, pre-transplant diagnosis of PVT, perioperative course and managements, relapse of PVT, early post-operative mortality and morbidity. All patients received liver from deceased donors, underwent thrombendvenectomy with end-to-end anastomosis without interposition graft and evaluated daily for 5 days and thereafter, biweekly by duplex sonography during the follow-up period for 2 months. They were treated by therapeutic doses of heparin followed by warfarin to maintain an INR of 2&amp;ndash;2.5.Results: The causes of end-stage liver disease were hepatitis B in 11, cryptogenic cirrhosis in 11, primary sclerosingcholangitis in 5 and other causes in 8 recipients. Extension of thrombosis was through confluence of superior mesenteric and splenic vein in 32 and to superior mesenteric vein in 3 patients. The mean&amp;plusmn;SD operation time was 7.2&amp;plusmn;1.5 hrs. The mean&amp;plusmn;SD transfusion requirement was 5.4&amp;plusmn;2.8 units of packed cells. The mean&amp;plusmn;SD duration of hospital stay in these patients was 17.7&amp;plusmn;10.9 days. Eight patients died; 1 developed early in-hospital PVT, 1 had hepatic vein thrombosis, and 1 died of in-hospital ischemic cerebrovascular accident, despite a full anticoagulant therapy. The mean&amp;plusmn;SD follow-up period for those 28 patients discharged from hospital was 16.6&amp;plusmn;7.9 months; none of them developed relapse of PVT. The overall mortality and morbidity was 28% and 32%, respectively. There was no relapse of PVT in the other patients.Conclusion: The presence of PVT at the time of OLT is not a contraindication for the operation but those with PVT have a more difficult surgery, develop more postoperative complications, and experience a higher in-hospital mortality.</Abstract></Article></ArticleSet>
